October 2021
-
Valeo Pharma’s Redesca™ rollout is progressing rapidly, proving the value of its business model, as its revenue grows 280% in Q3, 2021
Valeo Pharma Inc. (CSE: VPH | OTCQB: VPHIF | FSE: VP2) (“Valeo”) is a specialty pharmaceutical marketing company…
-
Jack Lifton and Constantine Karayannopoulos discuss the non-Chinese rare earths’ markets
In a recent InvestorIntel interview, Jack Lifton spoke with Constantine Karayannopoulos, President, CEO and Director of Neo Performance Materials…
-
Neo Performance’s Constantine Karayannopoulos on the growth opportunities for rare earths in the EV market
In a recent InvestorIntel interview, Tracy Weslosky spoke with Constantine Karayannopoulos, President, CEO and Director of Neo Performance…
-
Uranium Finance gets ahead of Climate Politics
A new (state owned) company, ANU Energy OEIC Ltd, in the Republic of Kazakhstan made the following announcement…
-
U.S. nuclear power generation at historical heights as investors buy uranium
There has been a lot of talks lately about fossil fuel energy source prices rising, particularly coal and…
